Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin Irritation of Chlorhexidine Gluconate Formulations
NCT04942496Phase 4Unknown
- Sponsor
- Mölnlycke Health Care
- Start
- Jun 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of chlorhexidine in surgical site infection (SSI) (11 arms), sponsored by Mölnlycke Health Care. Primary endpoint: Visual Evaluation of Skin Condition at 96 hours. Status: unknown.
02
Drugs
chlorhexidine
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04942496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04942496.